Computerised chest radiograph analysis revealed that the surfactant treatment led to better aeration in the right lung than in the left lung among infants born extremely preterm with respiratory ...

Please provide your email address to receive an email when new articles are posted on . Minimally invasive surfactant therapy did not lower mortality among preterm infants with respiratory distress ...

HealthDay News — The FDA has approved Surfaxin (lucinactant) to prevent respiratory distress syndrome (RDS) in premature infants. Premature infants born before 37 weeks’ gestation often cannot produce ...

Researchers have found in a new cohort study of preterm infants that completing full antenatal corticosteroid (ACS) courses ...

In a recent study published in Nature Communications, researchers investigate the risk of respiratory distress (RD) in neonates born to mothers with severe acute respiratory syndrome coronavirus 2 ...

Nasal intermittent positive pressure ventilation (NIPPV) reduced the risk of requiring invasive ventilation and developing bronchopulmonary dysplasia by nearly half compared with nasal continuous ...

Could AI predict preterm births before symptoms arise? A new study finds that machine learning models, especially SVMs, can assess risk with impressive accuracy—offering hope for earlier interventions ...